Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease.
Li G, Lin J, Zhang C, Gao H, Lu H, Gao X, Zhu R, Li Z, Li M, Liu Z. · 2021
Read Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease. by Li G, Lin J, Zhang C, Gao H, Lu H, Gao X, Zhu R, Li Z, Li M, Liu Z. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8437544.txt.
Description
Li and co-authors study butyrate, a gut microbe product, and its grip on neutrophils in bowel disease. Talk between host and microbes keeps the gut in balance. How metabolites steer neutrophils in inflammatory bowel disease was still unclear.
The team took neutrophils from patients and healthy donors and tested their signals. Butyrate sharply cut the cells' output of inflammatory cytokines and chemokines. It also curbed their movement and their release of web-like traps. A drug that mimics one of butyrate's actions copied the effect. In mice with colitis, butyrate eased gut lining inflammation. The work marks butyrate as a brake on harmful neutrophil action.
Catalog record
| CREATOR | Li G, Lin J, Zhang C, Gao H, Lu H, Gao X, Zhu R, Li Z, Li M, Liu Z. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |